Abstract
Purpose
Bone loss has been found to occur frequently in patients with particular metabolic disorders that are likely associated with certain kidney stone composition. Thus, we compared the bone mineral density (BMD) of patients with different kidney stone compositions.
Patients and methods
A total of 204 consecutive patients who exhibited stone formation with calcium oxalate (CaOx), calcium phosphate (CaP), uric acid (UA), and magnesium ammonium phosphate (MAP) underwent 24 h urine test and BMD measurement. BMD was measured by dual X-ray absorptiometry at the lumbar spine (LS) and femoral neck (FN). The Z-score was used to express BMD. A BMD Z-score ≤ − 2 was defined as a diagnostic threshold for bone loss.
Results
Amongst the patients, 38 had an LS BMD Z-score of ≤ − 2, but only 2 had FN BMD Z-score of ≤ − 2. The group with an LS BMD Z-score of ≤ − 2 exhibited significantly larger male − female ratio, higher frequency of hypercalciuria and CaP, and lower frequency of MAP than the group with an LS BMD Z-score of > − 2. Reduced LS BMD was most remarkable in the CaP group, followed by the CaOx, UA, and MAP groups. The LS BMD Z-score of hypercalciuric patients was significantly lower than that of normocalciuric patients only in the CaP group.
Conclusion
Patients with different kidney stone compositions presented different BMD status. Using this information may facilitate medical decision-making in patients with kidney stone who should undergone BMD earlier.
Similar content being viewed by others
Data availability
All relevant data are within the paper.
References
Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol 35:1301–1320
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120:109–116
Alhava EM, Juuti M, Karjalainen P (1976) Bone mineral density in patients with urolithiasis. A preliminary report. Scand J Urol Nephrol 10:154–156
Melton LR, Crowson CS, Khosla S, Wilson DM, O’Fallon WM (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53:459–464
Lewiecki EM, Gordon CM, Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S, Bishop NJ, Leonard MB, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS (2008) Special report on the 2007 adult and pediatric position development conferences of the International Society for Clinical Densitometry. Osteoporos Int 19:1369–1378
Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393–403
Tasca A, Dalle CL, Nigro F, Giannini S (2009) Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis. Urology 74:22–27
Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A, Croppi E, Gambaro G, Heilberg IP (2018) Defining metabolic activity of nephrolithiasis—appropriate evaluation and follow-up of stone formers. Asian J Urol 5:235–242
Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W, Sirikulchayanonta V, Ongphiphadhanakul B, Radinahamed P, Karnsombut P, Kunkitti N, Ruang-raksa C, Rajatanavin R (2001) Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 59:1086–1093
Silva BC, Bilezikian JP (2021) Skeletal abnormalities in hypoparathyroidism and in primary hyperparathyroidism. Rev Endocr Metab Disord 22:789–802
Fabris A, Bernich P, Abaterusso C, Marchionna N, Canciani C, Nouvenne A, Zamboni M, Lupo A, Gambaro G (2009) Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol 4:1974–1979
Hsi RS, Sanford T, Goldfarb DS, Stoller ML (2017) The role of the 24-hour urine collection in the prevention of kidney stone recurrence. J Urol 197:1084–1089
Hesse A, Straub M (2006) Rational evaluation of urinary stone disease. Urol Res 34:126–130
Kourambas J, Aslan P, Teh CL, Mathias BJ, Preminger GM (2001) Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol 15:181–186
Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26–32
Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston K, Preminger GM, Turk TMT, White JR (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324
Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L (2003) Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 42:1177–1183
Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, Stefoni S (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266
Elkoushy MA, Jundi M, Lee TT, Andonian S (2014) Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre. Can Urol Assoc J 8:323–328
Briot K, Cortet B, Tremollieres F, Sutter B, Thomas T, Roux C, Audran M (2009) Male osteoporosis: diagnosis and fracture risk evaluation. Jt Bone Spine 76:129–133
Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23:2735–2748
McKiernan FE, Berg RL, Linneman JG (2011) The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis. Osteoporos Int 22:1069–1077
Pietschmann F, Breslau NA, Pak CY (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388
Lauderdale DS, Thisted RA, Wen M, Favus MJ (2001) Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16:1893–1898
Sakhaee K, Maalouf NM, Poindexter J, Adams-Huet B, Moe OW (2017) Relationship between urinary calcium and bone mineral density in patients with calcium nephrolithiasis. J Urol 197:1472–1477
Shadman A, Bastani B (2017) Kidney calculi. Pathophysiology and as a systemic disorder. Iran J Kidney Dis 11:180–191
Haymann JP (2015) Metabolic disorders stones as first clinical manifestation of significant diseases. World J Urol 33:187–192
Funding
Supported by Jiangsu Province TCM Hospital Grants k2018ycx51.
Author information
Authors and Affiliations
Contributions
XC contributed to project development, data collection, manuscript writing and revision. LH contributed to data collection, data analysis, and revision. XW contributed to data collection and data analysis. LL contributed to data collection. XZ contributed to data collection. XC contributed to data collection. YX contributed to project development and revision.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethical approval
This study was approved by the Ethics Committee at the affiliated Hospital of Nanjing University of Chinese Medicine.
Informed consent
All patients were given a written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cong, X., Huang, L., Wang, X. et al. Comparison of the bone mineral density status of patients with kidney stones stratified by stone composition. World J Urol 42, 42 (2024). https://doi.org/10.1007/s00345-023-04727-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00345-023-04727-y